Viewing Study NCT02505750


Ignite Creation Date: 2025-12-24 @ 5:14 PM
Ignite Modification Date: 2025-12-25 @ 2:51 PM
Study NCT ID: NCT02505750
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-29
First Post: 2015-04-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety of a Boost (CXB or EBRT) in Combination With Neoadjuvant Chemoradiotherapy for Early Rectal Adenocarcinoma
Sponsor: Centre Antoine Lacassagne
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2014/14
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None UNKNOWN View
None UNKNOWN View
None OTHER View
None OTHER View
None OTHER View
None UNKNOWN View
None UNKNOWN View
None OTHER View
None OTHER View
None UNKNOWN View
None UNKNOWN View
None OTHER View
None UNKNOWN View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View